Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy
- Status
- SUSPENDED
- Phase
- NA
Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
MAX-10181 in Patients With Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1
Study of NIB101 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Quality Assurance on Anemia Management in Patients With Solid Tumors and Malignant Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Combination of YH003, YH001 and Pembrolizumab in Subjects with Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of AK119 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination With Chemotherapy or Toripalimab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
- Status
- TERMINATED
- Phase
- PHASE2
An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers
- Status
- COMPLETED
- Phase
- PHASE1